Aesop Cho

1.4k citations
24 papers · 906 indexed · h-index 15
Topics
Hepatitis C virus research (11 papers)HIV/AIDS drug development and treatment (10 papers)Biochemical and Molecular Research (9 papers)
Partner nations
United StatesFranceJapan

In The Last Decade

Aesop Cho

23 papers receiving 871 citations

Peers

Aesop Cho
Comparison fields: 5 of 72
  • Infectious Diseases 450
  • Molecular Biology 326
  • Epidemiology 254
  • Organic Chemistry 168
  • Hepatology 162
Replace Vickie Brown‐Driver with:
Vickie Brown‐Driver United States
Hsu‐Tso Ho United States
Pornwaratt Niyomrattanakit Singapore
David Orr Germany
Ana Shulla United States
Robert J. Fenton United Kingdom
Irvin Winkler Germany
Anastasia L. Khandazhinskaya Russia
Keith P. Romano United States
Anita Y. M. Howe United States
Aesop Cho relative to Vickie Brown‐Driver United States Vickie Brown‐Driver's profile →
Citations per field
00.5×4.3×
Vickie Brown‐Driver · 1×
Citations per year

Countries citing papers authored by Aesop Cho

Since Specialization
Citations

This map shows the geographic impact of Aesop Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aesop Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aesop Cho more than expected).

Fields of papers citing papers by Aesop Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aesop Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aesop Cho. The network helps show where Aesop Cho may publish in the future.

Co-authorship network of co-authors of Aesop Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Aesop Cho. A scholar is included among the top collaborators of Aesop Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aesop Cho. Aesop Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 254
3 3
4 2
5 26
6 27
7 156
8 98
9 8
10 28
11 18
12 21
13 18
14 13
15 43
16 17
17 7
18 55
19 9
20 16

About Aesop Cho

Aesop Cho is a scholar working on Hepatology, Molecular Medicine and Infectious Diseases, having authored 24 papers that have together received 906 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (10 papers) and Biochemical and Molecular Research (9 papers). The work is most often cited by research in Infectious Diseases (450 citations), Hepatology (162 citations) and Molecular Medicine (89 citations). Aesop Cho has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Adrian S. Ray, Joy Y. Feng, Choung U. Kim, Jie Xu, Thomas Butler, Jason K. Perry, Jennifer E. Vela, Oliver L. Saunders, T.C. Appleby and Mary E. McGrath. Their work appears in journals such as Science, Antimicrobial Agents and Chemotherapy and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026